Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dahuoluo Dan (also known as Da Huo Luo Dan or Da Huo Luo Wan) is a traditional Chinese patent medicine manufactured by Beijing Tong Ren Tang. It is a complex multi-herb formula containing approximately 50 active ingredients, including Agkistrodon acutus, Aconitum kusnezoffii, Aconite root, artificial bezoar, Black-necked snake, Gastrodia elata, cooked rhubarb, artificial musk, Sanguisorba officinalis, Rehmannia glutinosa, Arisaema consanguineum, and buffalo horn concentrated powder. It is traditionally used to dispel wind, eliminate dampness, relax muscles and tendons, and activate the collaterals. Clinically, it is indicated for the treatment of limb pain, numbness of hands and feet, muscle and bone stiffness, movement difficulties, and post-stroke complications such as hemiplegia, facial paralysis (crooked mouth and eyes), and slurred speech caused by wind-cold-dampness.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Dahuoluo Dan.